| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |